Stoke Therapeutics, Inc. short interest in 2024
In 2024, Stoke Therapeutics, Inc.'s disclosed short interest ran from 7.70% of shares outstanding on 12 Jan 2024 to 14.12% on 31 Dec 2024, a change of +6.42 percentage points. The year's high was 22.24% on 15 Jul 2024 and its low 7.67% on 15 Mar 2024, averaging 14.21% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 33.01 days on 31 Jan 2024. Full history: Stoke Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 7.70% (12 Jan 2024)
- End of year
- 14.12% (31 Dec 2024)
- Change
- +6.42 pp
- High
- 22.24% (15 Jul 2024)
- Low
- 7.67% (15 Mar 2024)
- Average
- 14.21%
- Highest days to cover
- 33.01 (31 Jan 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 7.70% | 17.65 | |
| 31 Jan 2024 | 9.24% | 33.01 | |
| 15 Feb 2024 | 8.88% | 25.16 | |
| 29 Feb 2024 | 8.43% | 12.73 | |
| 15 Mar 2024 | 7.67% | 12.12 | |
| 28 Mar 2024 | 10.69% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2024 | 11.95% | 4.71 | |
| 30 Apr 2024 | 17.95% | 9.15 | |
| 15 May 2024 | 17.09% | 10.94 | 10-Q filed, results (8-K) |
| 31 May 2024 | 17.75% | 9.97 | |
| 14 Jun 2024 | 18.06% | 13.19 | |
| 28 Jun 2024 | 20.44% | 7.27 | |
| 15 Jul 2024 | 22.24% | 19.42 | |
| 31 Jul 2024 | 18.64% | 18.15 | |
| 15 Aug 2024 | 18.78% | 26.23 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 17.58% | 25.19 | |
| 13 Sep 2024 | 16.55% | 18.31 | |
| 30 Sep 2024 | 13.26% | 7.74 | |
| 15 Oct 2024 | 12.89% | 10.36 | |
| 31 Oct 2024 | 12.65% | 22.33 | |
| 15 Nov 2024 | 12.09% | 12.32 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 12.72% | 13.27 | |
| 13 Dec 2024 | 13.70% | 9.77 | |
| 31 Dec 2024 | 14.12% | 10.30 |
See also: Stoke Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.